Sophomer s.r.o.

Sophomer s.r.o. is an academic startup that specializes in the development and production of synthetic polymers for in vitro diagnostics. The company's core technology bridges the fields of polymer chemistry and immunology to create tailored materials that replace traditional, animal-derived components like bovine serum albumin (BSA). Their flagship product, SophoMer F10, is a fully synthetic polymer that functions as a highly effective, non-specific binding blocker in immunochemical assays. By providing a chemically defined, animal component-free alternative, Sophomer ensures precise batch-to-batch reproducibility and eliminates the risk of pathogenic contaminants associated with animal-derived reagents. The startup was founded in 2022 through a technology transfer collaboration involving the Institute of Macromolecular Chemistry of the CAS, Elisa Development, and the bio-innovation center i&i Prague.

The technology is designed to make immunochemical assays faster, easier, and more cost-effective for developers and researchers. It is applicable across diverse sectors, including biochemical laboratories, the development of in vitro diagnostic (IVD) devices, environmental contamination monitoring, food allergen testing, and veterinary diagnostics. By simplifying the assay development process and enhancing measurement accuracy, Sophomer supports global diagnostics manufacturers in improving their kits. The company remains highly flexible, leveraging its strong academic ties to offer customized polymer variants in terms of purity and physical form, and is currently expanding its product pipeline with additional polymer developments supported by venture capital funding.